Processa Pharmaceuticals, Inc. (PCSA) Total liabilities 2016–2022
Processa Pharmaceuticals, Inc. (PCSA) total liabilities at each fiscal year-end, per SEC filings.
$1.1MFY2022 · since FY2016: $97,692 → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $1.1M | +17.4% |
| FY2021 | $978,405 | — |
| FY2016 | $97,692 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PCSA financial trends
PCSA RevenuePCSA Net incomePCSA Net marginPCSA Gross profitPCSA Gross marginPCSA Operating incomePCSA Operating marginPCSA Operating cash flowPCSA Free cash flowPCSA Capital expendituresPCSA Return on equityPCSA Stock buybacksPCSA Dividends paidPCSA Total assetsPCSA Shareholders’ equityPCSA overview →